Drug Database
TE

teriparatide (Xinfutai)

✓ Approved

Shenzhen Salubris Pharmaceuticals Co., Ltd. · PTH1R · 重组蛋白

什么是 teriparatide?

teriparatide 是一种重组蛋白,由Shenzhen Salubris Pharmaceuticals Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Subcutaneous Injection。

药物档案

商品名Xinfutai
公司Shenzhen Salubris Pharmaceuticals Co., Ltd.
药物类别重组蛋白
分子靶点PTH1R
给药途径Injectable (Others), Subcutaneous Injection
状态Approved

作用机制

分子靶点

teriparatide 作用于 1 个分子靶点:

PTH1Rparathyroid hormone 1 receptor (PTHR, EKNS)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

teriparatide 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersOsteoporosis✓ Approved

相关研究文献

PubMedBMC oral health2026-11-19

Comparative evaluation of the effect of whey protein powder and plant-based protein powder on the microhardness, sorption, and solubility of a nano-hybrid giomer restorative composite: an in vitro study.

Babre Pranjali P, Bohora Aarti A, Patel Pawan P, Sharma Vinay V et al.

Whey and plant protein powders are becoming common additions of people concerned with fitness in their diet. Consumed repeatedly as reconstituted shakes, these products remain in contact with the dentition for extended periods and introduce a chemically heterogeneous mixture of organic acids, fermentable carbohydrates, and bioactive phytochemicals capable of altering the oral environment. Acidic beverages and sports drinks are well documented to compromise resin-based restorative materials, yet comparative data on whey versus plant-based protein powders are lacking. An investigation using an in vitro method of analysis evaluated the effect of the whey protein powder and plant protein powder on the water sorption and solubility of the nano-hybrid giomer restorative composite. Fifty-six disc-shaped Beautifil II a nano-hybrid universal restorative composite incorporating Giomer technology and S-PRG fillers specimens were fabricated and allocated to three immersion groups: WPP, PBP, and distilled water control, with an additional independent baseline group for pre-immersion microhardness assessment. The specimens were exposed to freshly prepared solutions for 10 min at 37 °C daily for 15 days. Vickers microhardness was evaluated using a standardized indentation protocol, while water sorption and water solubility were assessed using a gravimetric mass-difference procedure based on ISO 4049. Specimen-level Wsp and Wsl values were calculated in µg/mm³. Normality was measured by using the Shapiro-Wilk test. The Kruskal-Wallis test followed by Dunn-Bonferroni post-hoc analysis was used for intergroup comparisons of microhardness. Water solubility was compared among the three immersion groups using the Kruskal-Wallis test followed by Bonferroni-adjusted pairwise comparisons, whereas water sorption was reported descriptively because of measurement-resolution limitations. Post-immersion microhardness was highest in the PBP group (86.33 ± 9.54 VHN), followed by WPP (83.93 ± 7.25 VHN), the independent pre-immersion baseline group (80.33 ± 9.46 VHN), and the distilled-water control (80.14 ± 9.48 VHN). After Bonferroni correction, PBP showed significantly higher microhardness than distilled water (adjusted p = 0.041), but its difference from the independent baseline group did not remain significant after adjustment; WPP showed no significant change relative to any comparator. Water solubility differed significantly among the three-immersion media (Kruskal-Wallis, p = 0.001). Mean Wsl was 371.36 ± 87.13 µg/mm³ for PBP, 148.54 ± 108.80 µg/mm³ for WPP, and 137.93 ± 92.85 µg/mm³ for distilled water. PBP demonstrated significantly higher Wsl than WPP (adjusted p = 0.0069) and distilled water (adjusted p = 0.0025), whereas WPP did not differ significantly from distilled water. Mean Wsp was 159.15 ± 150.05 µg/mm³ for PBP, 0.00 ± 115.68 µg/mm³ for WPP, and 26.53 ± 166.61 µg/mm³ for distilled water. Plant-based protein powder produced significantly higher microhardness than distilled water and significantly higher water solubility than both whey protein powder and distilled water, while whey protein powder showed no significant effect on either outcome relative to the neutral control. These preliminary findings are limited to the tested products and experimental conditions. They should not be extrapolated directly to clinical deterioration or used to support specific patient-management recommendations without confirmation from broader laboratory and clinical studies.

PMID 43052983
阅读全文 →
PubMedBMC nutrition2026-11-19

The effects of royal jelly consumption on glycemia indices, lipid profile, and blood pressure in patients with acute ischemic stroke: a randomized, triple-blind trial.

Karimi Elham E, Arab Arman A, Mansouri-Tehrani Hajar-Alsadat HA, Nehls Marilyn S MS et al.

The effects of royal jelly (RJ) on cardiometabolic risk factors in patients with acute ischemic stroke have not been previously reported from this trial. Therefore, we conducted a secondary analysis to investigate the effects of RJ consumption on glycemic indices, lipid profile, and blood pressure. Sixty-four ischemic stroke patients were enrolled in this study and were randomized into the RJ (n = 32) and placebo (n = 32) groups. The trial consisted of a 12-week intervention in which patients consumed either an RJ or a placebo supplement once daily after breakfast. The RJ supplement comprised 30% RJ powder (the equivalent of 1,000 mg of fresh RJ), 53% honey powder, and 17% filler, whereas the placebo comprised 53% honey powder and 47% filler. Post-stroke metabolic profile measures were assessed pre- and post-intervention, including glycemic indices [fasting plasma glucose (FPG), triglyceride glucose index (TyG)], blood pressure measures [systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP)], and lipid profiles [total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), non-HDL-C, cholesterol ratio, and triglycerides (TG)]. Following 12 weeks of RJ consumption, MAP [adjusted mean difference (AMD), -4.12 mmHg; 95% CI, -7.95 to -0.29] and FPG (AMD, -13.64 mg/dL; 95% CI, -26.42 to -0.86) were significantly reduced compared to the placebo. Moreover, the TyG index tended to decrease following RJ consumption compared to the control group (AMD, -0.12; 95% CI, -0.29 to 0.04). RJ consumption did not significantly alter other metabolic outcomes in the current study. We found that RJ consumption, in addition to standard treatments, for 12 weeks among patients with acute ischemic stroke may improve metabolic outcomes, including MAP and FPG. Further studies are needed to corroborate these preliminary findings. Iranian Registry of Clinical Trials (IRCT20180818040827N4), registered on October 9, 2021 https//www.irct.ir/trial/59,275.

PMID 43053256
阅读全文 →
PubMedBMC chemistry2026-11-19

Extractive ion-pair spectrophotometric methods utilizing bromocresol green to estimate chlorpheniramine maleate in pharmaceutical formulations.

Murshed Fatima A FA, Al-Mawri Siham H A SHA, Abdulrahman Sameer A M SAM

Two accurate, sensitive, and cost-effective spectrophotometric methods were developed and validated for the quantitative determination of Chlorpheniramine Maleate (CPM). Method A is based on the formation of a yellow ion-pair complex between CPM and bromocresol green (BCG) in an acidic medium. The resulting complex is extracted into dichloromethane, and its absorbance is measured at 414 nm. Method B involves the dissociation of the yellow-colored CPM-BCG ion-pair complex in a basic medium, leading to the development of a blue color that gives a maximum absorbance at 618 nm. Beer's law was found to be valid within the concentration ranges of 1.00-25.0 µg/mL for method A and 0.20-9.00 µg/mL for method B. The molar absorptivities were determined and found to be 1.76 × 104 and 4.47 × 104 L/(mol.cm) for methods A and B, respectively, with Sandell sensitivity values of 0.0222 and 0.0087 µg/cm². Detection and quantification limits were determined and found to be 0.2049 and 0.6210 µg/mL for method A, and 0.0199 and 0.0603 µg/mL for method B, respectively. The linearity was excellent with correlation coefficients of 0.9995 and 0.9997 for methods A and B. The developed methods were successfully employed to determine CPM in both its pure form and commercial pharmaceutical formulations. The methods were highly precise, with relative standard deviations between 0.24% and 1.85%, and highly accurate, with recovery percentages ranging from 98.14% to 100.8% when applied to pharmaceutical formulations. Statistical comparison with the official USP HPLC method showed no significant differences in accuracy or precision, making the developed methods ideal for routine quality control in resource-limited settings.

PMID 43053190
阅读全文 →
PubMedRespiratory research2026-11-19

Association between sodium-glucose cotransporter 2 inhibitors and the risk of chronic lower respiratory disease in type 2 diabetes mellitus: findings from two target trial emulations.

Li Yuhao Y, Lv Yiqiao Y, Dai Yongqi Y, Zeng Huatang H et al.

Research on the association between sodium‑glucose cotransporter 2 inhibitors (SGLT-2i) and chronic lower respiratory diseases (CLRDs) in patients with type 2 diabetes (T2DM) remains limited. This study aimed to investigate this association and examine the potential modifying effects such as age, sex, and diabetes severity. Using the Shenzhen Public Health Data Platform, we conducted two independent target trial emulations with a new‑user active comparator design, comparing SGLT‑2i with glucagon‑like peptide‑1 receptor agonists (GLP-1RA) and dipeptidyl peptidase‑4 inhibitors (DPP‑4i), respectively. The primary outcome was incident CLRD; secondary outcomes included five subtypes-bronchitis, bronchiectasis, asthma, chronic obstructive pulmonary disease, and emphysema. Overlap-weighted Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs). During a median follow-up of 1.76 years, 349 (7.95%) and 397 (9.04%) new CLRD cases occurred in SGLT-2i and GLP-1RA users, respectively. Compared with GLP-1RA, SGLT-2i use was associated with a lower CLRD incidence (HR 0.87, 95% CI 0.79-0.96), primarily driven by reduced risk of bronchitis (HR: 0.89; 95% CI: 0.79-1.00) and asthma (HR: 0.77; 95% CI: 0.58-1.01); no significant associations were found for other subtypes. Compared with DPP-4i, SGLT-2i use showed a trend toward lower CLRD risk (HR: 0.95; 95% CI: 0.91-0.99), with significant reductions for bronchitis (HR: 0.95; 95% CI: 0.91-1.00), bronchiectasis (HR: 0.86; 95% CI: 0.75-1.00), and asthma (HR: 0.87; 95% CI: 0.77-0.98). Subgroup analyses indicated significant interactions for bronchiectasis by sex (P interaction = 0.001). Compared with GLP-1 RA, SGLT-2i were associated with a significantly lower risk of CLRDs, driven predominantly by bronchitis; versus DPP-4i, the risk reduction was primarily observed for bronchitis, bronchiectasis, and asthma. The protective association between SGLT-2i use and bronchiectasis was more pronounced in females than in males relative to DPP-4i.

PMID 43053103
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Geometry-Induced Construction of Sub-Stoichiometric 3D Covalent Organic Frameworks for SO2 Capture.

Chang Jianhong J, Guo Ziang Z, Zhang Jie J, Zhang Zeyue Z et al.

Three-dimensional covalent organic frameworks (3D COFs) have emerged as a rapidly growing class of crystalline porous materials, yet reported structures adhere to the reticular chemistry paradigm of fully connected building blocks. Here, we report a geometry-induced construction strategy that enables the synthesis of sub-stoichiometric 3D COFs─JUC-748, JUC-749, and JUC-750─by deliberately combining building blocks with similar geometries but distinct connectivity. Their structures are determined by continuous rotation electron diffraction and powder X-ray diffraction, revealing that connectivity incompatibility enforces partial condensation and leaves unreacted aldehyde groups periodically arrayed along the pore walls. The frameworks exhibit Brunauer-Emmett-Teller surface areas up to 2836 m2 g-1, and the spatially ordered aldehyde modified pores create a highly favorable adsorption environment for SO2. Remarkably, JUC-748 achieves a SO2 uptake of 16.9 mmol g-1 at 298 K and 1 bar, representing one of the highest values reported for porous organic materials to date. This work establishes geometry-induced construction as a powerful and general strategy for creating intrinsically functionalized 3D COFs with ordered reactive sites, high porosity, and excellent adsorption performance.

PMID 43053452
阅读全文 →
PubMedEssays in biochemistry2026-11-19

The donated chemical probe programme: advancing biomedical research through open science.

Haeberle Sandra S, Tredup Claudia C

Chemical probes enable selective modulation of protein function in live cells, making them valuable tools for studying the roles of proteins in normal and disease physiology. Although initiatives such as the chemical probe development programme at the Structural Genomics Consortium have expanded access to chemial probes for selected target classes, the general availability across the druggable proteome remains limited, particularly for compounds developed within the pharmaceutical industry. The donated chemical probe (DCP) programme addresses this gap through an open-science model that combines unrestricted access to donated probes with comprehensive characterisation data and independent expert review. Since its launch in 2017, the programme has become an important resource for basic as well as translational research. More than 20 organisations have contributed to the initiative, resulting in a collection of about 140 chemical probes together with matched control compounds and previously inaccessible characterisation data that had often remained confined to patents or internal reports. The present review summarises recent developments of the DCP programme and highlights representative examples including case studies such as the BUB1 chemical probe BAY 1816032.

PMID 43053520
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多teriparatide